A Prospective Observational Study of the Efficacy and Safety of CPT-11 Based Regimens for UGT1A1 Genotype Guided Patients With Metastatic Colorectal Cancer.

Trial Profile

A Prospective Observational Study of the Efficacy and Safety of CPT-11 Based Regimens for UGT1A1 Genotype Guided Patients With Metastatic Colorectal Cancer.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Oct 2016

At a glance

  • Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid; Gimeracil/oteracil/tegafur
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 11 Oct 2016 Results evaluating a monogram for predicting overall survival presented at the 41st European Society for Medical Oncology Congress.
    • 13 Jul 2016 Status changed from active, no longer recruiting to completed.
    • 07 Jun 2016 Results of impact of UGT1A1 genotype on overall survival presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top